Sino Biopharmaceutical Statistics

Total Valuation

SBMFF has a market cap or net worth of 8.93 billion. The enterprise value is 9.71 billion.

Market Cap	8.93B
Enterprise Value	9.71B

Important Dates

The next estimated earnings date is Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Sep 10, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.36%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.85B

Valuation Ratios

The trailing PE ratio is 18.63.

PE Ratio	18.63
Forward PE	n/a
PS Ratio	2.26
PB Ratio	1.52
P/TBV Ratio	2.12
P/FCF Ratio	11.53
P/OCF Ratio	9.85
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.34, with an EV/FCF ratio of 12.54.

EV / Earnings	20.26
EV / Sales	2.46
EV / EBITDA	10.34
EV / EBIT	12.48
EV / FCF	12.54

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.

Current Ratio	1.26
Quick Ratio	1.11
Debt / Equity	0.23
Debt / EBITDA	1.39
Debt / FCF	1.72
Interest Coverage	19.66

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 7.02%.

Return on Equity (ROE)	11.82%
Return on Assets (ROA)	5.62%
Return on Invested Capital (ROIC)	7.02%
Return on Capital Employed (ROCE)	12.65%
Revenue Per Employee	162,220
Profits Per Employee	19,668
Employee Count	24,379
Asset Turnover	0.45
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.67% in the last 52 weeks. The beta is 0.75, so SBMFF's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+56.67%
50-Day Moving Average	0.39
200-Day Moving Average	0.54
Relative Strength Index (RSI)	63.06
Average Volume (20 Days)	4,145

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SBMFF had revenue of 3.95 billion and earned 479.49 million in profits. Earnings per share was 0.03.

Revenue	3.95B
Gross Profit	3.22B
Operating Income	794.79M
Pretax Income	723.03M
Net Income	479.49M
EBITDA	944.33M
EBIT	794.79M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 2.03 billion in cash and 1.33 billion in debt, giving a net cash position of 699.73 million.

Cash & Cash Equivalents	2.03B
Total Debt	1.33B
Net Cash	699.73M
Net Cash Per Share	n/a
Equity (Book Value)	5.86B
Book Value Per Share	0.24
Working Capital	702.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 906.29 million and capital expenditures -131.54 million, giving a free cash flow of 774.76 million.

Operating Cash Flow	906.29M
Capital Expenditures	-131.54M
Free Cash Flow	774.76M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 20.10% and 12.12%.

Gross Margin	81.51%
Operating Margin	20.10%
Pretax Margin	18.28%
Profit Margin	12.12%
EBITDA Margin	23.88%
EBIT Margin	20.10%
FCF Margin	19.59%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.56%.

Dividend Per Share	0.01
Dividend Yield	1.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	52.76%
Buyback Yield	2.36%
Shareholder Yield	3.92%
Earnings Yield	5.37%
FCF Yield	8.67%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SBMFF has an Altman Z-Score of 2.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.75
Piotroski F-Score	n/a